Cargando…
In vivo mutagenicity assessment of orally treated tert-butyl hydroperoxide in the liver and glandular stomach of MutaMouse
BACKGROUND: tert-Butyl hydroperoxide (TBHP; CAS 75–91-2), a hydroperoxide, is mainly used as a polymerization initiator to produce polyethylene, polyvinyl chloride, and unsaturated polyester. It is a high-production chemical, widely used in industrial countries, including Japan. TBHP is also used as...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662197/ https://www.ncbi.nlm.nih.gov/pubmed/37990244 http://dx.doi.org/10.1186/s41021-023-00285-2 |
_version_ | 1785148521668673536 |
---|---|
author | Murata, Yasumasa Suzuki, Kenichiro Shigeta, Yoshiyuki Iso, Takako Hirose, Nozomu Umano, Takaaki Horibata, Katsuyoshi Sugiyama, Kei-ichi Hirose, Akihiko Masumura, Kenichi Matsumoto, Mariko |
author_facet | Murata, Yasumasa Suzuki, Kenichiro Shigeta, Yoshiyuki Iso, Takako Hirose, Nozomu Umano, Takaaki Horibata, Katsuyoshi Sugiyama, Kei-ichi Hirose, Akihiko Masumura, Kenichi Matsumoto, Mariko |
author_sort | Murata, Yasumasa |
collection | PubMed |
description | BACKGROUND: tert-Butyl hydroperoxide (TBHP; CAS 75–91-2), a hydroperoxide, is mainly used as a polymerization initiator to produce polyethylene, polyvinyl chloride, and unsaturated polyester. It is a high-production chemical, widely used in industrial countries, including Japan. TBHP is also used as an additive for the manufacturing of food utensils, containers, and packaging (UCP). Therefore, there could be consumer exposure through oral intake of TBHP eluted from UCPs. TBHP was investigated in various in vitro and in vivo genotoxicity assays. In Ames tests, some positive results were reported with and/or without metabolic activation. As for the mouse lymphoma assay, the positive result was reported, regardless of the presence or absence of metabolic activation enzymes. The results of some chromosomal aberrations test and comet assay in vitro also demonstrated the genotoxic positive results. On the other hand, in in vivo tests, there are negative results in the bone marrow micronucleus test of TBHP-administered mice by single intravenous injection and the bone marrow chromosomal aberration test using rats exposed to TBHP for 5 days by inhalation. Also, about dominant lethal tests, the genotoxic positive results appeared. In contrast, there is little information about in vivo mutagenicity and no information about carcinogenicity by oral exposure. RESULTS: We conducted in vivo gene mutation assay using MutaMice according to the OECD Guidelines for the Testing of Chemicals No. 488 to investigate in vivo mutagenicity of TBHP through oral exposure. After repeated dosing for 28 days, there were no significant differences in the mutant frequencies (MFs) of the liver and glandular stomach up to 300 mg/kg/day (close to the maximum tolerable dose (MTD)). The positive and negative controls produced the expected responses. CONCLUSIONS: These findings show that orally administrated TBHP is not mutagenic in the mouse liver and glandular stomach under these experimental conditions. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41021-023-00285-2. |
format | Online Article Text |
id | pubmed-10662197 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-106621972023-11-21 In vivo mutagenicity assessment of orally treated tert-butyl hydroperoxide in the liver and glandular stomach of MutaMouse Murata, Yasumasa Suzuki, Kenichiro Shigeta, Yoshiyuki Iso, Takako Hirose, Nozomu Umano, Takaaki Horibata, Katsuyoshi Sugiyama, Kei-ichi Hirose, Akihiko Masumura, Kenichi Matsumoto, Mariko Genes Environ Short Report BACKGROUND: tert-Butyl hydroperoxide (TBHP; CAS 75–91-2), a hydroperoxide, is mainly used as a polymerization initiator to produce polyethylene, polyvinyl chloride, and unsaturated polyester. It is a high-production chemical, widely used in industrial countries, including Japan. TBHP is also used as an additive for the manufacturing of food utensils, containers, and packaging (UCP). Therefore, there could be consumer exposure through oral intake of TBHP eluted from UCPs. TBHP was investigated in various in vitro and in vivo genotoxicity assays. In Ames tests, some positive results were reported with and/or without metabolic activation. As for the mouse lymphoma assay, the positive result was reported, regardless of the presence or absence of metabolic activation enzymes. The results of some chromosomal aberrations test and comet assay in vitro also demonstrated the genotoxic positive results. On the other hand, in in vivo tests, there are negative results in the bone marrow micronucleus test of TBHP-administered mice by single intravenous injection and the bone marrow chromosomal aberration test using rats exposed to TBHP for 5 days by inhalation. Also, about dominant lethal tests, the genotoxic positive results appeared. In contrast, there is little information about in vivo mutagenicity and no information about carcinogenicity by oral exposure. RESULTS: We conducted in vivo gene mutation assay using MutaMice according to the OECD Guidelines for the Testing of Chemicals No. 488 to investigate in vivo mutagenicity of TBHP through oral exposure. After repeated dosing for 28 days, there were no significant differences in the mutant frequencies (MFs) of the liver and glandular stomach up to 300 mg/kg/day (close to the maximum tolerable dose (MTD)). The positive and negative controls produced the expected responses. CONCLUSIONS: These findings show that orally administrated TBHP is not mutagenic in the mouse liver and glandular stomach under these experimental conditions. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41021-023-00285-2. BioMed Central 2023-11-21 /pmc/articles/PMC10662197/ /pubmed/37990244 http://dx.doi.org/10.1186/s41021-023-00285-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Short Report Murata, Yasumasa Suzuki, Kenichiro Shigeta, Yoshiyuki Iso, Takako Hirose, Nozomu Umano, Takaaki Horibata, Katsuyoshi Sugiyama, Kei-ichi Hirose, Akihiko Masumura, Kenichi Matsumoto, Mariko In vivo mutagenicity assessment of orally treated tert-butyl hydroperoxide in the liver and glandular stomach of MutaMouse |
title | In vivo mutagenicity assessment of orally treated tert-butyl hydroperoxide in the liver and glandular stomach of MutaMouse |
title_full | In vivo mutagenicity assessment of orally treated tert-butyl hydroperoxide in the liver and glandular stomach of MutaMouse |
title_fullStr | In vivo mutagenicity assessment of orally treated tert-butyl hydroperoxide in the liver and glandular stomach of MutaMouse |
title_full_unstemmed | In vivo mutagenicity assessment of orally treated tert-butyl hydroperoxide in the liver and glandular stomach of MutaMouse |
title_short | In vivo mutagenicity assessment of orally treated tert-butyl hydroperoxide in the liver and glandular stomach of MutaMouse |
title_sort | in vivo mutagenicity assessment of orally treated tert-butyl hydroperoxide in the liver and glandular stomach of mutamouse |
topic | Short Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662197/ https://www.ncbi.nlm.nih.gov/pubmed/37990244 http://dx.doi.org/10.1186/s41021-023-00285-2 |
work_keys_str_mv | AT muratayasumasa invivomutagenicityassessmentoforallytreatedtertbutylhydroperoxideintheliverandglandularstomachofmutamouse AT suzukikenichiro invivomutagenicityassessmentoforallytreatedtertbutylhydroperoxideintheliverandglandularstomachofmutamouse AT shigetayoshiyuki invivomutagenicityassessmentoforallytreatedtertbutylhydroperoxideintheliverandglandularstomachofmutamouse AT isotakako invivomutagenicityassessmentoforallytreatedtertbutylhydroperoxideintheliverandglandularstomachofmutamouse AT hirosenozomu invivomutagenicityassessmentoforallytreatedtertbutylhydroperoxideintheliverandglandularstomachofmutamouse AT umanotakaaki invivomutagenicityassessmentoforallytreatedtertbutylhydroperoxideintheliverandglandularstomachofmutamouse AT horibatakatsuyoshi invivomutagenicityassessmentoforallytreatedtertbutylhydroperoxideintheliverandglandularstomachofmutamouse AT sugiyamakeiichi invivomutagenicityassessmentoforallytreatedtertbutylhydroperoxideintheliverandglandularstomachofmutamouse AT hiroseakihiko invivomutagenicityassessmentoforallytreatedtertbutylhydroperoxideintheliverandglandularstomachofmutamouse AT masumurakenichi invivomutagenicityassessmentoforallytreatedtertbutylhydroperoxideintheliverandglandularstomachofmutamouse AT matsumotomariko invivomutagenicityassessmentoforallytreatedtertbutylhydroperoxideintheliverandglandularstomachofmutamouse |